Argonaut Technologies' Stockholders Approve Sale of Assets to Biotage
Argonaut Technologies announced that its stockholders have approved the sale of the assets of its chemistry consumables business and certain assets of its process chemistry business, which constitute substantially all of its assets except for its cash, to Biotage AB of Uppsala, Sweden. Argonaut and Biotage expect to close the transaction on June 3, 2005.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Researchers boost production of biofuel that could replace gasoline
New technology spots drugs' early impact on cancer - Fox Chase researchers find that tool could help discover new compounds or drug combinations, and quickly identify the most effective treatments for individual tumors
BASF Venture Capital invests in biotechnology company Advanced BioNutrition Corp.